Company Overview of Phenomix Corporation
On October 26, 2010, Phenomix Corporation went out of business. Phenomix Corporation, a biopharmaceutical company, engages in the discovery, development, and commercialization of small-molecule product candidates. Its product candidate includes PHX1149, a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes. The company's product candidate also includes PHX1766, which is a protease inhibitor for the treatment of hepatitis C virus infection. It focuses its small-molecule drug discovery efforts on enzyme targets, including proteases, kinases, and polymerases. Phenomix Corporation was founded in 2001 and is headquartered in San Diego, California.
5930 Cornerstone Court West
San Diego, CA 92121
Founded in 2001
Key Executives for Phenomix Corporation
Phenomix Corporation does not have any Key Executives recorded.
Similar Private Companies By Industry
|Glycostasis, Inc.||United States|
|Plaxgen, Inc.||United States|
|Ercole Biotech, Inc.||United States|
|BioMarker Pharmaceuticals, Inc.||United States|
|Kona Medical, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Phenomix Corporation, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.